Dexlansoprazole
RxNorm 816346
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 816346 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: dexlansoprazole.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Dexlansoprazole
(Atom ID: 2959911)
PTPrescribable
Designated preferred name (PT):
Dexlansoprazole
(Atom ID: 2985604)
FNPrescribable
Full form of descriptor (FN):
Dexlansoprazole (substance)
(Atom ID: 2985607)
PTPrescribable
Designated preferred name (PT):
Dexlansoprazole-containing product
(Atom ID: 10801025)
FNPrescribable
Full form of descriptor (FN):
Product containing dexlansoprazole (medicinal product)
(Atom ID: 9724034)
Patient Education
Dexlansoprazole
Dexlansoprazole is used to treat the symptoms of gastroesophageal reflux disease (GERD; a condition in which backward flow of acid from the stomach causes heartburn and possible injury of the esophagus [tube between the throat and stomach]) in adults and children 12 years of age and older. It is also used to treat esophagitis (swelling that may damage tissues of the esophagus) in adults and children 12 years of age and older. Dexlansoprazole is used for the maintenance treatment of esophagitis and healing in adults and children 12 years of age and older. Dexlansoprazole is in a class of medications called proton pump inhibitors. It works by decreasing the amount of acid made in the stomach.
[Learn More]
* Please review the disclaimer below.